CTRU Holdings of CareDx (CDNA) - Updated Daily

Join Premium Plan

Shares HeldWeight In Fund

The CTRU ETF is not an actively managed fund. There are no daily trades and the weighting is equal for all holdings. The holdings here are therefore considered outside the normal analysis for Cathie's Ark. However, the fund is still run by Ark Investment so it's worth paying attention to.

Key Statistics

Statistics

🕵🏼Found In	🏷Last Price
ARKGCTRU	$38.70
⚖️Weighting	🧢Market Cap
1.05%	$2.05b
💳ARK Estimated Cost Average	🧮Price to Sales
	6.92
🎫ARK Ownership Percent	🌏Country
0.01%	🇺🇸United States

Description
CareDx, Inc., headquartered in South San Francisco, California, is a leading precision medicine solutions company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the leading provider of genomics-based information for transplant patients.
Website
www.caredx.com

Research Notes and Commentary for CDNA

November 1, 2021

October 28-29: ARK Trades and Storylines

Trading Floor

August 3, 2020

#233: Homeownership in the US is Skyrocketing, & More

See Section #4

March 22, 2020

R&D Should Be Considered an Asset, Not an Expense, Particularly in the Genomics Industry

See Section #5